JUNE 04, 2025 — The biotech and pharmaceutical sectors exist in an age of unprecedented complexity and accelerating change, where crises can break out at any moment and touch everything from patient safety to company survival. On the current day, crisis leadership expert Dr. Bagrat Lalayan publishes his long-awaited book, Leading in Crisis, an authoritative manual intended to prepare executives, managers, and teams across these crucial industries with the strategies and techniques required to navigate effectively through crises and maintain long-term resilience.
Drawing on over two decades of experience across clinical development, medical affairs, and commercial operations, Dr. Lalayan offers an insider’s perspective on the unique challenges that pharma and biotech leaders face from clinical trial failures and regulatory upheavals to workforce reductions and supply chain disruptions. His comprehensive approach integrates practical case studies, cutting-edge technology insights, and human-centered leadership techniques.
Key Highlights of Leading in Crisis Include:
• Understanding Crisis Dynamics: A close examination of the anatomy of pharmaceutical and biotech crises, and how innovation, regulatory pressure, and market forces collide to create pressing problems.
• Building a Crisis-Ready Culture: Best practices for building and enabling cross-functional teams that lead with clarity, emotional intelligence, and foresight.
• Decision-Making Under Pressure: New models such as the OODA Loop and case studies illustrating how to bridge data-driven analytics with intuitive leadership.
• Maintaining Long-Term Resilience: Techniques to infuse sustainability and flexibility into organizational DNA via ongoing learning, ESG integration, and scalable crisis management systems.
• Navigating Mastering Crisis Communication: Methods for open, empathetic communication with stakeholders, regulators, patients, and staff to uphold trust amidst turmoil.
• Harnessing Technology: How new tools like AI-driven predictive analytics, digital dashboards, and incident management software revolutionize crisis response and decision-making.
• Maneuvering Regulatory Compliance: Balancing tough regulatory standards with the need to innovate quickly and responsibly.
Leading in Crisis also provides practical exercises for reflection and interactive components, allowing leaders to translate lessons directly back to their organizations and come out stronger from adversity.
Why This Book Matters
Pharmaceutical and biotech companies are at the forefront of some of the most pressing global health issues. Crisis leadership doesn't just determine business results but significantly influences patient outcomes and global health. Leading in Crisis by Dr. Bagrat Lalayan is a valuable guidebook that offers practical advice and a template for crisis leaders who are dedicated to excellence in uncertain times.
About the Author
Dr. Bagrat Lalayan comes with over 20 years of pharmaceutical industry experience, working in clinical development, medical affairs, and commercial operations. His area of expertise is the ability to drive agility in high-stakes settings, innovation, and teams through intricate regulatory environments.
Dr. Lalayan interest is in empowering executives to lead with integrity and resilience in a crisis.
To inquire about media, review copies, or interviews, please email:
[Dr. Bagrat Lalayan]
[818-987-2066]
[[email protected]]
[[email protected]]